• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tema Oncology ETF (NQ:CANC)

36.48 +0.61 (+1.70%)
Official Closing Price Updated: 4:15 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 107,884
Open 36.47
Bid (Size) 18.23 (200)
Ask (Size) 54.69 (200)
Prev. Close 35.87
Today's Range 36.30 - 36.66
52wk Range 20.10 - 36.67
Shares Outstanding N/A
Dividend Yield 0.05%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Did GLUE Stock Surge Over 50% In Premarket Today? ↗
January 07, 2026
Monte Rosa Therapeutics reported positive interim Phase 1 data for MRT-8102, showing significant anti-inflammatory effects in patients with elevated cardiovascular risk. 
Via Stocktwits
News headline image
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance
December 02, 2025
From Tema ETFs
Via Business Wire

Performance

YTD
+5.5%
+5.5%
1 Month
+5.6%
+5.6%
3 Month
+23.4%
+23.4%
6 Month
+41.3%
+41.3%
1 Year
+49.1%
+49.1%

More News

Read More
News headline image
AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK ↗
November 25, 2025
Via Stocktwits
News headline image
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market ↗
April 25, 2024
Via Investor's Business Daily
News headline image
Healthcare ETFs For The Weight-Loss Drug Boom And Beyond ↗
April 08, 2024
Via Talk Markets
Topics Artificial Intelligence ETFs
News headline image
Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will it be a Boost For Pharma Stocks Too? ↗
December 05, 2023
Via Benzinga
News headline image
EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads ↗
December 01, 2023
Via Benzinga
Topics ETFs
News headline image
Active ETFs Appear Booming In 2023 — Tema ETFs Are Taking Them Into A New Direction ↗
November 28, 2023
Via Benzinga
Topics ETFs
News headline image
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF? ↗
November 21, 2023
Via Benzinga
Topics ETFs

Frequently Asked Questions

Is Tema Oncology ETF publicly traded?
Yes, Tema Oncology ETF is publicly traded.
What exchange does Tema Oncology ETF trade on?
Tema Oncology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Tema Oncology ETF?
The ticker symbol for Tema Oncology ETF is CANC on the Nasdaq Stock Market
What is the current price of Tema Oncology ETF?
The current price of Tema Oncology ETF is 36.48
When was Tema Oncology ETF last traded?
The last trade of Tema Oncology ETF was at 01/09/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap